首页> 外国专利> isolated polypeptide comprising an immunogenic portion of a M vaccine antigen, use in the treatment and diagnosis of mycobacterial infections

isolated polypeptide comprising an immunogenic portion of a M vaccine antigen, use in the treatment and diagnosis of mycobacterial infections

机译:分离的多肽,包含M疫苗抗原的免疫原性部分,用于治疗和诊断分枝杆菌感染

摘要

The isolated polypeptide comprises an immunogenic portion of M. vaccae antigen. The antigen includes a sequence selected from: a) sequences recites in SEQ ID 1-4, 9-16, 18-21, 23, 25, 26, 28, 29, 44, 45, 47, 52-55, 63, 64, 70, 75, 89, 94, 98, 100-105, 109, 110, 112, 121, 124, 125, 134, 135, 140 and 141 depicted in the specification and b) sequences having at least 99% probability of being the same as sequence recited in SEQ ID 1-4, 9-16, 18-21, 23, 25, 26, 28, 29, 44, 45, 47, 52-55, 63, 64, 70, 75, 89, 94, 98, 100-105, 109, 110, 112, 121, 124, 125, 134, 135, 140 and 141 depicted in the specification as measured by computer algorithm BLASTP or the antigen comprises an amino acid sequence encoded by a DNA molecule selected from: c) sequences recited in SEQ ID: 40-42, 46, 48-51, 74, 88, 93, 97, 99, 106-108, 111, 120, 122, 123, 132, 133 and 136-138 depicted in the specification; d) complements of SEQ ID: 40-42, 46, 48-51, 74, 88, 93, 97, 99, 106-108, 111, 120, 122, 123, 132, 133 and 136-138 depicted in the specification and e) sequences having at least 99% probability of being the same as sequence of c) and d) as measured by a computer algorithm FASTA. SEQ ID 1 is Ala, Pro, Val, Gly, Pro, Gly, Xaa, Ala, Ala, Tyr, Val, Gln, Gln, Val, Pro, Asp, Gly, Pro, Gly, Ser, Val, Gln, Gly, Met, Ala. An isolated DNA molecule having a nucleotide sequence encoding the above-defined polypeptide, the expression vector and the host cell thereof are disclosed. A pharmaceutical composition and vaccine thereof useful for inducing protective immune in a patient.
机译:分离的多肽包含牛痘分枝杆菌抗原的免疫原性部分。抗原包括选自以下的序列:a)SEQ ID 1-4、9-16、18-21、23、25、26、28、29、44、45、47、52-55、63、64的序列规范中所述的70、75、89、94、98、100-105、109、110、112、121、124、125、134、135、140和141以及b)具有至少99%的概率成为序列与SEQ ID 1-4、9-16、18-21、23、25、26、28、29、44、45、47、52-55、63、64、70、75、89,通过计算机算法BLASTP测得的说明书中所述的94、98、100-105、109、110、112、121、124、125、134、135、140和141或抗原包含由DNA分子编码的氨基酸序列选自:c)SEQ ID:40-42、46、48-51、74、88、93、97、99、106-108、111、120、122、123、132、133和136-138中所述的序列在说明书中描述; d)说明书中描述的SEQ ID:40-42、46、48-51、74、88、93、97、99、106-108、111、120、122、123、132、133和136-138的互补物e)通过计算机算法FASTA测得的序列与c)和d)的序列具有至少99%的概率相同的序列。 SEQ ID 1是Ala,Pro,Val,Gly,Pro,Gly,Xaa,Ala,Ala,Tyr,Val,Gln,Gln,Val,Pro,Asp,Gly,Pro,Gly,Ser,Val,Gln,Gly,公开了一种具有编码上述多肽的核苷酸序列的分离的DNA分子,表达载体及其宿主细胞。可用于在患者中诱导保护性免疫的药物组合物及其疫苗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号